Edward Kai-Hua Chow
Edward Kai-Hua Chow
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Mechanisms of chemoresistance in cancer stem cells
LN Abdullah, EKH Chow
Clinical and translational medicine 2, 1-9, 2013
Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment
EK Chow, XQ Zhang, M Chen, R Lam, E Robinson, H Huang, D Schaffer, ...
Science translational medicine 3 (73), 73ra21-73ra21, 2011
Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice
A Shahangian, EK Chow, X Tian, JR Kang, A Ghaffari, SY Liu, JA Belperio, ...
The Journal of clinical investigation 119 (7), 1910-1920, 2009
Toll-like receptors induce a phagocytic gene program through p38
SE Doyle, RM O'Connell, GA Miranda, SA Vaidya, EK Chow, PT Liu, ...
The Journal of experimental medicine 199 (1), 81-90, 2004
Cancer nanomedicine: from drug delivery to imaging
EKH Chow, D Ho
Science translational medicine 5 (216), 216rv4-216rv4, 2013
Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection
AK Perry, EK Chow, JB Goodnough, WC Yeh, G Cheng
The Journal of experimental medicine 199 (12), 1651-1658, 2004
Epigenetics in cancer stem cells
TB Toh, JJ Lim, EKH Chow
Molecular cancer 16, 1-20, 2017
Exosomes in cancer nanomedicine and immunotherapy: prospects and challenges
NL Syn, L Wang, EKH Chow, CT Lim, BC Goh
Trends in biotechnology 35 (7), 665-676, 2017
Accelerating the translation of nanomaterials in biomedicine
S Mitragotri, DG Anderson, X Chen, EK Chow, D Ho, AV Kabanov, ...
ACS nano 9 (7), 6644-6654, 2015
Multimodal nanodiamond drug delivery carriers for selective targeting, imaging, and enhanced chemotherapeutic efficacy
XQ Zhang, R Lam, X Xu, EK Chow, HJ Kim, D Ho
Advanced materials 23 (41), 4770-4775, 2011
Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4
SE Doyle, R O’Connell, SA Vaidya, EK Chow, K Yee, G Cheng
The Journal of Immunology 170 (7), 3565-3571, 2003
Nanodiamonds: The intersection of nanotechnology, drug development, and personalized medicine
D Ho, CHK Wang, EKH Chow
Science Advances 1 (7), e1500439, 2015
Epirubicin-adsorbed nanodiamonds kill chemoresistant hepatic cancer stem cells
X Wang, XC Low, W Hou, LN Abdullah, TB Toh, M Mohd Abdul Rashid, ...
ACS nano 8 (12), 12151-12166, 2014
Enabling technologies for personalized and precision medicine
D Ho, SR Quake, ERB McCabe, WJ Chng, EK Chow, X Ding, BD Gelb, ...
Trends in biotechnology 38 (5), 497-518, 2020
Nanodiamond vectors functionalized with polyethylenimine for siRNA delivery
M Chen, XQ Zhang, HB Man, R Lam, EK Chow, D Ho
The Journal of Physical Chemistry Letters 1 (21), 3167-3171, 2010
Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy
Y Zhao, TWH Shuen, TB Toh, XY Chan, M Liu, SY Tan, Y Fan, H Yang, ...
Gut 67 (10), 1845-1854, 2018
Clinical applications of carbon nanomaterials in diagnostics and therapy
KP Loh, D Ho, GNC Chiu, DT Leong, G Pastorin, EKH Chow
Advanced Materials 30 (47), 1802368, 2018
Biocompatibility assessment of detonation nanodiamond in non-human primates and rats using histological, hematologic, and urine analysis
L Moore, J Yang, TTH Lan, E Osawa, DK Lee, WD Johnson, J Xi, ...
ACS nano 10 (8), 7385-7400, 2016
Diamond‐lipid hybrids enhance chemotherapeutic tolerance and mediate tumor regression
L Moore, EKH Chow, E Osawa, JM Bishop, D Ho
Advanced materials 25 (26), 3532-3541, 2013
Polymer nanofilm coatings
D Ho, M Chen, E Pierstorff, H Huang, EK Chow, G Cheng
US Patent 8,263,104, 2012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20